Dr. Klaus Kratochwill is a translational biomedical researcher in Vienna. He obtained his MSc in chemistry at the Vienna University of Technology and then received his PhD in 2009 at the Medical University of Vienna (MUV) at the Department of Pediatrics and Adolescent Medicine. He was head of the research laboratory of the spin-off company Zytoprotec, where he and his colleagues successfully developed a novel fluid for peritoneal dialysis from in-vitro discovery to clinical application.
Using a systems biology approach previous work yielded insight into intracellular events and functional pathways in models of experimental peritoneal dialysis and thereby identified inadequate or suppressed cellular stress responses (CSR) in mesothelial cells exposed to peritoneal dialysis fluids as a novel pathomechanism.
Klaus Kratochwill is member of the board of the Austrian Proteomics Association (AuPA). He also was one of the principal investigators of an EU funded project including research institutes and industry throughout 8 EU member states. In 2014 Klaus Kratochwill was a visiting researcher at Harvard Medical School.
Since 2016, Klaus Kratochwill heads the “Christian Doppler Laboratory for Molecular Stress Research in Peritoneal Dialysis (CDL-MSRPD)” which aims to identify molecular stress signatures as surrogate markers of clinical outcome in peritoneal dialysis, and to identify novel cytoprotective additives and characterize their molecular mode of action.